In late October, Abliva will attend the 14th Mitochondrial Disease Conference, this year in Padua (IT), organized by the Italian patient organization Mitocon. Abliva's CMO, Magnus Hansson will attend the session: Roundtable with Pharmaceutical Industries and Regulatory Authorities. Read more by following the link below.